US Bancorp’s BIOATLA INC BCAB Stock Holding History

US Bancorp’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5	Closed	-$1K	–	4079
2022 Q1	$1K	Buy	5 +1	+25%	+$418	﹤0.01%	3912
2021 Q4	$3K	Sell	4 -3	-43%	-$3.84K	﹤0.01%	3772
2021 Q3	$11K	Buy	7 +6	+600%	+$11.7K	﹤0.01%	3389
2021 Q2	$2K	Buy	+1	New	+$2.26K	﹤0.01%	3799

Other funds holding BCAB

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

US Bancorp's BCAB Position: Q2 2022 in Review

US Bancorp sold out of BIOATLA INC (BCAB) in Q2 2022, closing a stake of 5 shares — an estimated $1K sold.

US Bancorp first reported a position in BCAB in Q2 2021 and held it in 4 quarters. The position peaked at $11K in Q3 2021. 76 funds tracked by Wall St. Rank hold BCAB as of Q2 2022.

US Bancorp reported no remaining BIOATLA INC position as of Q2 2022 after selling out during the quarter.
US Bancorp sold 5 BIOATLA INC shares in Q2 2022, an estimated $1K.
US Bancorp first reported a position in BIOATLA INC in Q2 2021 and held it in 4 quarters.
US Bancorp's BIOATLA INC position peaked at $11K in Q3 2021.
76 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2022.

Based on US Bancorp's 13F filing for Q2 2022, filed 1 Aug 2022.